Axoltis pharma is a biopharmaceutical company dedicated to develop first-in-class disease-modifying drugs to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.
| Website | http://www.axoltis.com |
| Employees | 11 (7 on RocketReach) |
| Address | 60, Avenue Rockefeller, Lyon, Auvergne-Rhône-Alpes 69008, FR |
| Phone | +33 4 72 62 17 36 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical, Drug Development, First In Class Drugs, Biotechnology, Pharmaceutical, Neurodegenerative Diseases, Pharmaceutical Research, Innovative Therapies, Traumatic Brain Injury, Neurological Disorders, Drug Discovery, Therapeutics, Unmet Medical Needs, Central Nervous System, Medical Research, Clinical Trials, Regenerative Medicine, Patient Care |
| Competitors | Novartis, Roche, Pfizer, Bristol Myers Squibb, Merck & Co., Inc., AstraZeneca, Gilead Sciences, AbbVie, Johnson & Johnson, Sanofi +46 more (view full list) |
Looking for a particular Axoltis pharma employee's phone or email?
Yann Godfrin is the CEO of Axoltis pharma.
7 people are employed at Axoltis pharma.
Axoltis pharma is based in Lyon, Auvergne-Rhône-Alpes.